drugset / Trial / NCT00569621

A Randomized, Double-Masked, Placebo-Controlled Two Cross Over Study Comparing the Effects of Moxaverine and Placebo on Ocular Blood Flow

NCT00569621 ↗

Phase 2 Completed 16 enrolled Medical University of Vienna
RandomizedCrossoverQuadruple-blindTreatment

Summary

It is known that several common eye diseases are associated with ocular perfusion abnormalities. Moxaverine is used in the therapy of perfusion abnormalities in the brain, the heart and the extremities because of its direct vasodilatory effects. The present study seeked to investigate whether moxaverine alters ocular blood flow in healthy volunteers after intravenous administration.

Timeline

Start
2007-03
Primary completion
—
Completion
2007-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Moxaverine Small molecule — Intravenous

Indications